Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.

D'Avola D, Cuervas-Mons V, Martí J, Ortiz de Urbina J, Lladó L, Jimenez C, Otero E, Suarez F, Rodrigo JM, Gómez MA, Fraga E, Lopez P, Serrano MT, Rios A, Fábrega E, Herrero JI.

Liver Transpl. 2017 Apr;23(4):498-509. doi: 10.1002/lt.24738.

2.

Influence of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with antiviral triple therapy.

Puente Á, Cabezas J, López Arias MJ, Fortea JI, Arias MT, Estébanez Á, Casafont F, Fábrega E, Crespo J.

Rev Esp Enferm Dig. 2017 Jan;109(1):17-25. doi: 10.17235/reed.2016.4235/2016.

3.

De Novo Donor-Specific Anti-Human Leukocyte Antigen Antibody Detection in Long-Term Adult Liver Transplantation.

San Segundo D, Alonso C, Ruiz P, Romon I, Arias-Loste MT, Cuadrado A, Puente A, Casafont F, López-Hoyos M, Crespo J, Fábrega E.

Transplant Proc. 2016 Nov;48(9):2980-2982. doi: 10.1016/j.transproceed.2016.08.037. Erratum in: Transplant Proc. 2017 Oct;49(8):1963.

PMID:
27932124
4.

Serum Levels of Interleukin-34 During Acute Rejection in Liver Transplantation.

San Segundo D, Ruiz P, Irure J, Arias-Loste MT, Cuadrado A, Puente A, Casafont F, López-Hoyos M, Crespo J, Fábrega E.

Transplant Proc. 2016 Nov;48(9):2977-2979. doi: 10.1016/j.transproceed.2016.08.038.

PMID:
27932123
5.

Effect of environmental enrichment and herbal compound supplementation on physiological stress indicators (chromogranin A, cortisol and tumour necrosis factor-α) in growing pigs.

Casal N, Manteca X, Escribano D, Cerón JJ, Fàbrega E.

Animal. 2017 Jul;11(7):1228-1236. doi: 10.1017/S1751731116002561. Epub 2016 Dec 8.

PMID:
27927261
6.

Successful Continuation of HCV Treatment After Liver Transplantation.

Fernández Carrillo C, Crespo G, de la Revilla J, Castells L, Buti M, Montero JL, Fábrega E, Fernández I, Serrano-Millán C, Hernández V, Calleja JL, Londoño MC.

Transplantation. 2017 May;101(5):1009-1012. doi: 10.1097/TP.0000000000001596.

PMID:
27906834
7.

Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.

Arias-Loste MT, Iruzubieta P, Puente Á, Ramos D, Santa Cruz C, Estébanez Á, Llerena S, Alonso-Martín C, San Segundo D, Álvarez L, López Useros A, Fábrega E, López-Hoyos M, Crespo J.

Int J Mol Sci. 2016 Nov 10;17(11). pii: E1878.

8.

Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.

Morlán-Coarasa MJ, Arias-Loste MT, Ortiz-García de la Foz V, Martínez-García O, Alonso-Martín C, Crespo J, Romero-Gómez M, Fábrega E, Crespo-Facorro B.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3947-3952. Epub 2016 Sep 12.

PMID:
27620899
9.

High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.

Boix F, Millan O, San Segundo D, Mancebo E, Rimola A, Fabrega E, Fortuna V, Mrowiec A, Castro-Panete MJ, Peña Jde L, Llorente S, Minguela A, Bolarin JM, Paz-Artal E, Lopez-Hoyos M, Brunet M, Muro M.

Immunobiology. 2016 May;221(5):595-603. doi: 10.1016/j.imbio.2016.01.008. Epub 2016 Jan 25.

PMID:
26850323
10.

Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy.

Cabezas J, Llerena S, Puente Á, Fábrega E, Crespo J.

Rev Esp Enferm Dig. 2016 Jul;108(7):421-30. doi: 10.17235/reed.2015.3894/2015. Review.

11.

Binge drinking: Burden of liver disease and beyond.

Llerena S, Arias-Loste MT, Puente A, Cabezas J, Crespo J, Fábrega E.

World J Hepatol. 2015 Nov 28;7(27):2703-15. doi: 10.4254/wjh.v7.i27.2703. Review.

12.

Activated Regulatory T Cells Expressing CD4(+)CD25(high)CD45RO(+)CD62L(+) Biomarkers Could Be a Risk Factor in Liver Allograft Rejection.

Boix F, Millan O, San Segundo D, Mancebo E, Miras M, Rimola A, Fábrega E, Allende L, Minguela A, Paz-Artal E, López-Hoyos M, Brunet M, Muro M.

Transplant Proc. 2015 Oct;47(8):2380-1. doi: 10.1016/j.transproceed.2015.09.007.

PMID:
26518933
13.

Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma.

Agüero F, Forner A, Manzardo C, Valdivieso A, Blanes M, Barcena R, Rafecas A, Castells L, Abradelo M, Torre-Cisneros J, Gonzalez-Dieguez L, Salcedo M, Serrano T, Jimenez-Perez M, Herrero JI, Gastaca M, Aguilera V, Fabregat J, Del Campo S, Bilbao I, Romero CJ, Moreno A, Rimola A, Miro JM; FIPSE Investigators.

Hepatology. 2016 Feb;63(2):488-98. doi: 10.1002/hep.28321. Epub 2016 Jan 4.

PMID:
26516761
14.

Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Cuadrado A, San Segundo D, López-Hoyos M, Crespo J, Fábrega E.

World J Gastroenterol. 2015 Oct 21;21(39):11016-26. doi: 10.3748/wjg.v21.i39.11016. Review.

15.

The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease.

Arias-Loste MT, Fábrega E, López-Hoyos M, Crespo J.

Biomed Res Int. 2015;2015:319745. doi: 10.1155/2015/319745. Epub 2015 Sep 28. Review.

16.

Plasma betatrophin levels in patients with liver cirrhosis.

Arias-Loste MT, García-Unzueta MT, Llerena S, Iruzubieta P, Puente A, Cabezas J, Alonso C, Cuadrado A, Amado JA, Crespo J, Fábrega E.

World J Gastroenterol. 2015 Oct 7;21(37):10662-8. doi: 10.3748/wjg.v21.i37.10662.

17.

Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study.

Agüero F, Rimola A, Stock P, Grossi P, Rockstroh JK, Agarwal K, Garzoni C, Barcan LA, Maltez F, Manzardo C, Mari M, Ragni MV, Anadol E, Di Benedetto F, Nishida S, Gastaca M, Miró JM; FIPSE/NIH HIVTR/NEAT023 Investigators.

Am J Transplant. 2016 Feb;16(2):679-87. doi: 10.1111/ajt.13461. Epub 2015 Sep 28.

18.

[V Consensus Meeting of the Spanish Society for Liver Transplant on high-risk recipients, immunosupression scenarios and management of hepatocarcinoma on the transplant waiting list].

Pardo F, Pons JA, Briceño J; en nombre de la Sociedad Española de Trasplante Hepático.

Gastroenterol Hepatol. 2015 Dec;38(10):600-18. doi: 10.1016/j.gastrohep.2015.06.008. Epub 2015 Sep 26. Spanish.

PMID:
26404045
19.

High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation.

Boix-Giner F, Millan O, San Segundo D, Muñoz-Cacho P, Mancebo E, Llorente S, Rafael-Valdivia L, Rimola A, Fábrega E, Mrowiec A, Allende L, Minguela A, Bolarín JM, Paz-Artal E, López-Hoyos M, Brunet M, Muro M.

Int Immunol. 2016 Feb;28(2):55-64. doi: 10.1093/intimm/dxv048. Epub 2015 Aug 12.

20.

Animal welfare towards sustainability in pork meat production.

Velarde A, Fàbrega E, Blanco-Penedo I, Dalmau A.

Meat Sci. 2015 Nov;109:13-7. doi: 10.1016/j.meatsci.2015.05.010. Epub 2015 May 21.

PMID:
26013042

Supplemental Content

Loading ...
Support Center